Neuroblastoma trials in France

In France 11 Also abroad 128

11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
Where
Marseille, Paris, Villejuif
Age
18 months to 18 years
People
144 worldwide
Run by
Renaissance Pharma Ltd.
See details and how to joinNCT07549321 · EU 2025-524397-42-00
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Bordeaux, Lyon, Marseille, Nantes, Villejuif
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 1/2Taking people
A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
Where
Bordeaux, Lille, Paris, Toulouse, Vandoeuvre Les Nancy
Age
Up to 64 years
People
72 worldwide
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504880-18-00 · EU 2023-504880-18-00
No phaseTaking people
Engineering Immune Organoids to Study Pediatric Cancer
Where
Paris, Villejuif
Age
Up to 25 years
People
108
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT05890781
Phase 1/2Taking people
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Where
Bordeaux Cedex, Lille, Lyon, Marseille, Nantes, Paris, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy, Villejuif
Age
1 year to 64 years
People
160 worldwide
Run by
University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00
No phaseNot yet taking people in France
Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors
Where
Amiens, Besançon, Bordeaux, Brest, Bron, Caen, Dijon, Grenoble, Le Kremlin-Bicêtre, Lille, Limoges, Marseille, Montpellier, Nancy, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Denis, Strasbourg, Toulouse, Tours
Age
Up to 18 years
People
150
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06798532
Phase 2Not yet taking people in France
Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.
Where
Paris, Villejuif
Age
365 days to 17 years
People
30
Run by
Institut Curie
See details and how to joinNCT07111117
No phaseTaking people
Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method
Where
Clermont-Ferrand
Age
2 years to 45 years
People
89
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT07141862
No phaseTaking people
SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
Where
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Strasbourg, Toulouse, Tours, Vandœuvre-lès-Nancy, Villejuif
People
600 worldwide
Run by
Institut Curie
See details and how to joinNCT05192980
Phase 1Taking people
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
Where
Lille, Marseille, Villejuif
Age
18 months to 18 years
People
38 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06485947 · EU 2023-509673-22-00
Phase 3Taking people
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Where
Amiens Cedex 1, Angers, Besançon Cedex, Bordeaux, Brest, BULLION, Caen, Caen Cedex 5, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Lille, Limoges, Lyon, MARGENCY, Marseille, MONTPELLIER, Montpellier Cedex 05, Nantes, Nice, Nice Cedex 2, Paris, Pessac, Poitiers, Reims Cedex, Rennes, Rouen decex, Saint-Denis, Saint-Etienne, Saint-Herblain, Strasbourg, Toulouse Cedex 9, Tours, Vandoeuvre-lès-nancy, Vandoeuvre lès Nancy, Villejuif
Age
Up to 21 years
People
800 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00